MEDIZIN: Diskussion
Kritische Anmerkungen
Critical Remarks
Dtsch Arztebl Int 2012; 109(25): 445-6; DOI: 10.3238/arztebl.2012.0445b
| 1. | Luks AM, McIntosh SE, Grissom CK, Auerbach PS, Rodway GW, Schoene RB, et al.: Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med 2010; 21: 146–55. CrossRef MEDLINE |
| 2. | Schommer K, Wiesegart N, Menold E, Haas U, Lahr K, Buhl H, et al.: Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559m. High Alt Med Biol 2010; 11: 19–25. CrossRef MEDLINE |
| 3. | Basnyat B, Gertsch JH, Holck PS, Johnson EW, Luks AM, Donham BP, et al.: Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial. High Alt Med Biol 2006; 7: 17–27. CrossRef MEDLINE |
| 4. | Schommer K, Bärtsch P: Basic medical advice for travelers to high altitudes. Dtsch Arztebl Int 2011; 108(49): 839–48. VOLLTEXT |
